Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Neuroendocrine aspects of catamenial epilepsy.

Reddy DS.

Horm Behav. 2013 Feb;63(2):254-66. doi: 10.1016/j.yhbeh.2012.04.016. Epub 2012 May 2. Review.

2.

Neurosteroids and their role in sex-specific epilepsies.

Reddy DS.

Neurobiol Dis. 2014 Dec;72 Pt B:198-209. doi: 10.1016/j.nbd.2014.06.010. Epub 2014 Jun 21. Review.

3.

The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Reddy DS.

Epilepsy Res. 2009 Jul;85(1):1-30. doi: 10.1016/j.eplepsyres.2009.02.017. Epub 2009 Apr 29. Review.

4.

Role of neurosteroids in catamenial epilepsy.

Reddy DS.

Epilepsy Res. 2004 Dec;62(2-3):99-118. Review.

PMID:
15579299
5.

Catamenial Epilepsy: Discovery of an Extrasynaptic Molecular Mechanism for Targeted Therapy.

Reddy DS.

Front Cell Neurosci. 2016 Apr 22;10:101. doi: 10.3389/fncel.2016.00101. eCollection 2016. Review.

6.

Neurosteroid replacement therapy for catamenial epilepsy.

Reddy DS, Rogawski MA.

Neurotherapeutics. 2009 Apr;6(2):392-401. doi: 10.1016/j.nurt.2009.01.006. Review.

7.

Catamenial epilepsy: hormonal aspects.

Verrotti A, Laus M, Coppola G, Parisi P, Mohn A, Chiarelli F.

Gynecol Endocrinol. 2010 Nov;26(11):783-90. doi: 10.3109/09513590.2010.490606. Review.

PMID:
20518639
8.

Pharmacology of catamenial epilepsy.

Reddy DS.

Methods Find Exp Clin Pharmacol. 2004 Sep;26(7):547-61. Review.

PMID:
15538544
9.

Catamenial epilepsy: Update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial.

Herzog AG.

Seizure. 2015 May;28:18-25. doi: 10.1016/j.seizure.2015.02.024. Epub 2015 Feb 23. Review.

10.

Catamenial epilepsy.

Penovich PE, Helmers S.

Int Rev Neurobiol. 2008;83:79-90. doi: 10.1016/S0074-7742(08)00004-4. Review.

PMID:
18929076
11.

The neuroendocrine basis of sex differences in epilepsy.

Reddy DS.

Pharmacol Biochem Behav. 2017 Jan;152:97-104. doi: 10.1016/j.pbb.2016.07.002. Epub 2016 Jul 14. Review.

PMID:
27424276
12.

Catamenial epilepsy: definition, prevalence pathophysiology and treatment.

Herzog AG.

Seizure. 2008 Mar;17(2):151-9. doi: 10.1016/j.seizure.2007.11.014. Review.

13.

Catamenial epilepsy: pathophysiology, diagnosis, and management.

Foldvary-Schaefer N, Falcone T.

Neurology. 2003 Sep 1;61(6 Suppl 2):S2-15. Review.

PMID:
14504304
14.

Neurosteroids — Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy.

Reddy DS, Rogawski MA.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

15.

[Catamenial epilepsy].

Mehmedika-Suljić E, Alajbegović A, Loncarević N, Alajbegović S.

Med Arh. 2007;61(4):248-9. Review. Bosnian.

PMID:
18298002
16.

Hormones and seizures.

Foldvary-Schaefer N, Harden C, Herzog A, Falcone T.

Cleve Clin J Med. 2004 Feb;71 Suppl 2:S11-8. Review.

PMID:
15379295
17.

Reproductive endocrine considerations and hormonal therapy for women with epilepsy.

Herzog AG.

Epilepsia. 1991;32 Suppl 6:S27-33. Review.

PMID:
1959509
18.

Sex differences in the anticonvulsant activity of neurosteroids.

Samba Reddy D.

J Neurosci Res. 2017 Jan 2;95(1-2):661-670. doi: 10.1002/jnr.23853. Review.

19.

Management and health issues in women with epilepsy - a review.

Salawu FK, Moruppa JY, Danburam A, Olokoba AB.

Niger Postgrad Med J. 2011 Dec;18(4):288-94. Review.

PMID:
22448412
20.

A Treatment Approach to Catamenial Epilepsy.

Navis A, Harden C.

Curr Treat Options Neurol. 2016 Jul;18(7):30. doi: 10.1007/s11940-016-0413-6. Review.

PMID:
27188699

Supplemental Content

Support Center